{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:37:26Z","timestamp":1775151446410,"version":"3.50.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/meg.0b013e328330a8e8","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T08:46:01Z","timestamp":1262940361000},"page":"157-166","source":"Crossref","is-referenced-by-count":18,"title":["Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort"],"prefix":"10.1097","volume":"22","author":[{"given":"Thierry","family":"Morin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lahmek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rabaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Fran\u00e7ois","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/S0168-8278(06)80047-4","article-title":"Prevalence of hepatitis C in France, 2003-2004","volume":"44","author":"Meffre","year":"2006","journal-title":"J Hepatol"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1017\/S0950268807009417","article-title":"Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis surveillance system in France","volume":"136","author":"Brouard","year":"2008","journal-title":"Epidemiol Infect"},{"key":"R3-6-20210207","first-page":"994","article-title":"Acute hepatitis C: a retrospective study of 62 cases","volume":"26","author":"Morin","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"R4-6-20210207","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1590-8658(03)00007-0","article-title":"Natural course of acute hepatitis C: a long-term prospective study","volume":"35","author":"Santantonio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"R6-6-20210207","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"R7-6-20210207","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2004.02023.x","article-title":"Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response","volume":"20","author":"Delwaide","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon \u03b1-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"J Hepatol"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"R10-6-20210207","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"key":"R11-6-20210207","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of Peginterferon therapy in acute hepatitis C: a randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"R12-6-20210207","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1086\/520660","article-title":"Twelve-week treatment of acute hepatitis C Virus with Pegylated interferon \u03b1-2b in injection drug users","volume":"45","author":"De Rosa","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R13-6-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2006.07.003","article-title":"Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review","volume":"45","author":"Prati","year":"2006","journal-title":"J Hepatol"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/507640","article-title":"Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy","volume":"43","author":"Santantonio","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"R16-6-20210207","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jmv.20390","article-title":"Evolution over a 10 year period of the epidemiological profile of 1726 newly diagnosed HCV patients in Belgium","volume":"76","author":"G\u00e9rard","year":"2005","journal-title":"J Med Virol"},{"key":"R17-6-20210207","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0398-7620(06)76763-3","article-title":"Limited impact of the harm-reduction policy on HCV transmission among drug-users. The ANRS-Coquelicot survey example","volume":"54","author":"Jauffret-Roustide","year":"2006","journal-title":"Rev Epidemiol Sante Publique"},{"key":"R18-6-20210207","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2893.2006.00812.x","article-title":"High incidence of hepatitis C virus reinfection within a cohort of injecting drug users","volume":"14","author":"Micallef","year":"2007","journal-title":"J Viral Hepat"},{"key":"R19-6-20210207","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/gut.52.6.900","article-title":"Second infection with a different hepatitis C virus genotype in intravenous drug user during interferon therapy","volume":"52","author":"Asselah","year":"2003","journal-title":"Gut"},{"key":"R20-6-20210207","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(01)00111-8","article-title":"Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy","volume":"35","author":"Mele","year":"2001","journal-title":"J Hepatol"},{"key":"R21-6-20210207","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.03.001","article-title":"Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care?","volume":"48","author":"Deterding","year":"2008","journal-title":"J Hepatol"},{"key":"R22-6-20210207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJM199707243370404","article-title":"Patient to patient transmission of hepatitis C virus during colonoscopy","volume":"337","author":"Bronowicki","year":"1997","journal-title":"N Engl J Med"},{"key":"R23-6-20210207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2007.07.031","article-title":"Hospital admission is a relevant source of hepatitis C virus acquisition in Spain","volume":"48","author":"Martinez-Bauer","year":"2008","journal-title":"J Hepatol"},{"key":"R24-6-20210207","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/JCM.36.10.3040-3043.1998","article-title":"Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission","volume":"36","author":"Le Pogam","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R25-6-20210207","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/jhep.2002.36129","article-title":"Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies","volume":"36","author":"Larghi","year":"2002","journal-title":"Hepatology"},{"key":"R26-6-20210207","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jhin.2005.11.008","article-title":"Retrospective investigation of patients exposed to possible transmission of hepatitis C virus by a capillary blood glucose meter","volume":"63","author":"Kadi","year":"2006","journal-title":"J Hosp Infect"},{"key":"R27-6-20210207","doi-asserted-by":"crossref","first-page":"A1079","DOI":"10.1016\/S0399-8320(06)73471-6","article-title":"Outbreak of acute hepatitis C in a hemodialysis center. Epidemiology, virology, treatment and outcome after 4.5 years","volume":"30","author":"Duboc","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"R28-6-20210207","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/502613","article-title":"A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center","volume":"26","author":"Savey","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R29-6-20210207","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.hepres.2005.08.012","article-title":"Timing of interferon therapy and sources of infection in patients with acute hepatitis C","volume":"34","author":"Ogata","year":"2006","journal-title":"Hepatol Res"},{"key":"R30-6-20210207","first-page":"341A","article-title":"Acute hepatitis C: natural course and response to antiviral treatment","volume":"34","author":"Gerlach","year":"2001","journal-title":"Hepatology"},{"key":"R31-6-20210207","first-page":"S208","article-title":"Injury with hepatitis C (HCV)-contaminated needles in health care workers: what is the true rate of seroconversion?","volume":"46","author":"Kubitschke","year":"2006","journal-title":"J Hepatol"},{"key":"R33-6-20210207","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2893.2005.00605.x","article-title":"Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: the GEMHEP GenoCII Study","volume":"12","author":"Payan","year":"2005","journal-title":"J Viral Hepat"},{"key":"R34-6-20210207","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men link to high-risk sexual behaviours","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"key":"R35-6-20210207","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.aids.0000200541.40633.56","article-title":"Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy","volume":"20","author":"Serpaggi","year":"2006","journal-title":"AIDS"},{"key":"R36-6-20210207","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2807\/esm.10.05.00535-en","article-title":"Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004","volume":"10","author":"Gambotti","year":"2005","journal-title":"Eurosurveillance"},{"key":"R37-6-20210207","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.qai.0000174930.64145.a9","article-title":"Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin","volume":"40","author":"Gilleece","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-6-20210207","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/01.aids.0000226956.02719.fd","article-title":"Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients","volume":"20","author":"Dominguez","year":"2006","journal-title":"AIDS"},{"key":"R39-6-20210207","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/QAD.0b013e3282f5f4cf","article-title":"Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom","volume":"22","author":"Fox","year":"2008","journal-title":"AIDS"},{"key":"R40-6-20210207","first-page":"3","article-title":"Acute hepatitis C: changing epidemiology and association with HIV infection","volume":"12","author":"Brejt","year":"2007","journal-title":"J HIV Ther"},{"key":"R41-6-20210207","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"R42-6-20210207","first-page":"279A","article-title":"High rate of spontaneous clearance in patients with iatrogenic acute hepatitis C","volume":"44","author":"Licata","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"R43-6-20210207","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2893.1999.00006.x","article-title":"Role of the specific T-cell response for the clearance and control of hepatitis C virus","volume":"6","author":"Pape","year":"1999","journal-title":"J Viral Hepat"},{"key":"R44-6-20210207","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"Hofer","year":"2003","journal-title":"Hepatology"},{"key":"R45-6-20210207","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1053\/jhep.2003.50237","article-title":"Prediction of spontaneous viral clearance in acute hepatitis C by viral load measurements","volume":"37","author":"Berg","year":"2003","journal-title":"Hepatology"},{"key":"R46-6-20210207","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/595979","article-title":"Late appearance of hepatitis C virus RNA after needlestick injury: necessity for a more intensive follow-up","volume":"30","author":"Gruener","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R47-6-20210207","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/587843","article-title":"Impact of HIV on host-virus interactions during early hepatitis C virus infection","volume":"197","author":"Danta","year":"2008","journal-title":"J Infect Dis"},{"key":"R48-6-20210207","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/135965350601100817","article-title":"Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals","volume":"11","author":"Vogel","year":"2006","journal-title":"Antivir Ther"},{"key":"R49-6-20210207","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/gut.52.12.1784","article-title":"Treatment of hepatitis C 2002 French Consensus","volume":"52","author":"Dhumeaux","year":"2003","journal-title":"Gut"},{"key":"R50-6-20210207","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/QAD.0b013e3282f85daa","article-title":"The transforming growth factor-\u03b2 high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C","volume":"22","author":"Nattermann","year":"2008","journal-title":"AIDS"},{"key":"R51-6-20210207","first-page":"668A","article-title":"Early ribavirine improves sustained virological response in acute HCV infection in HIV+ individuals","volume":"42","author":"Danta","year":"2005","journal-title":"Hepatology"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042737-201002000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T15:52:38Z","timestamp":1739721158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042737-201002000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0b013e328330a8e8","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}